InvestLog
KALV logo

KALV

KalVista Pharmaceuticals, Inc.NASDAQHealthcare
$19.90+0.66%ClosedMarket Cap: $1.02B

As of 2026-04-06

Recent Analyst Ratings
DateFirmActionRatingPrevious
2026-03-26Stifel—Buy—
2026-03-26Citizens—Market Outperform—
2026-03-25Needham—Buy—
2026-01-09HC Wainwright & Co.—Buy—
2026-01-09Needham—Buy—
2025-12-04Needham—Buy—
2025-11-11Citizens—Market Outperform—
2025-09-12JMP Securities—Market Outperform—
2025-09-12Needham—Buy—
2025-07-11HC Wainwright & Co.—Buy—
Forward Estimates
PeriodEPS Est.Revenue Est.# Analysts
Fri Apr 30$-1.73$182.5M3
Sun Apr 30$0.64$310.9M6
Mon Apr 30$2.02$425.4M2
Tue Apr 30$3.12$513.0M2